Literature DB >> 9327735

Pulmonary hemodynamics modify the rat pulmonary artery response to injury. A neointimal model of pulmonary hypertension.

K Okada1, Y Tanaka, M Bernstein, W Zhang, G A Patterson, M D Botney.   

Abstract

Hemodynamic factors have profound influences on blood vessels. To test the hypothesis that hemodynamic conditions modify the pattern of remodeling in response to injury, monocrotaline (MCT) injury in Sprague-Dawley rats was followed 1 week later by left pneumonectomy to increase blood flow to the right lung. Right pulmonary artery remodeling in these MCT plus pneumonectomy animals was compared with animals receiving MCT or pneumonectomy alone. Neointimal changes developed in more than 90% of all right lung intra-acinar vessels 5 weeks after MCT injury (4 weeks after pneumonectomy). Neointimal lesions did not develop in untreated animals or in animals receiving MCT or pneumonectomy only. Animals with a neointimal pattern of remodeling developed severe right ventricular hypertrophy (RVH) whereas animals with a medial hypertrophy pattern of remodeling (MCT only) developed moderate RVH compared with control animals. Neointimal lesions and RVH were similar whether injury preceded pneumonectomy or vice versa. To exclude the possibility that neointimal lesions resulted from injury plus post-pneumonectomy compensatory lung growth, rather than injury plus increased flow, a left subclavian-pulmonary artery anastomosis was substituted for pneumonectomy. Neointimal lesions and severe RVH developed in these animals but were not seen in animals receiving either MCT or anastomosis only. These studies demonstrate an important role for hemodynamics in determining the pattern of pulmonary vascular remodeling after injury.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9327735      PMCID: PMC1858047     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  47 in total

1.  The postpneumonectomy state: clinical and physiologic observations in thirty-six cases.

Authors:  B BURROWS; R W HARRISON; W E ADAMS; E M HUMPHREYS; E T LONG; A F REIMANN
Journal:  Am J Med       Date:  1960-02       Impact factor: 4.965

2.  ATRIAL SEPTAL DEFECT WITH PULMONARY HYPERTENSION.

Authors:  E Besterman
Journal:  Br Heart J       Date:  1961-09

3.  Pulmonary circulation and alveolar ventilation perfusion relationships after pneumonectomy.

Authors:  A COURNAND; R L RILEY
Journal:  J Thorac Surg       Date:  1950-01

4.  Angiotensin converting enzyme expression in primary pulmonary hypertension.

Authors:  D P Schuster; E C Crouch; W C Parks; T Johnson; M D Botney
Journal:  Am J Respir Crit Care Med       Date:  1996-10       Impact factor: 21.405

5.  Fluid shear stress induces synthesis and nuclear localization of c-fos in cultured human endothelial cells.

Authors:  V Ranjan; S L Diamond
Journal:  Biochem Biophys Res Commun       Date:  1993-10-15       Impact factor: 3.575

6.  Regional heterogeneity of elastin and collagen gene expression in intralobar arteries in response to hypoxic pulmonary hypertension as demonstrated by in situ hybridization.

Authors:  I W Prosser; K R Stenmark; M Suthar; E C Crouch; R P Mecham; W C Parks
Journal:  Am J Pathol       Date:  1989-12       Impact factor: 4.307

7.  Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension.

Authors:  A Giaid; D Saleh
Journal:  N Engl J Med       Date:  1995-07-27       Impact factor: 91.245

8.  Extracellular matrix protein gene expression in atherosclerotic hypertensive pulmonary arteries.

Authors:  M D Botney; L R Kaiser; J D Cooper; R P Mecham; D Parghi; J Roby; W C Parks
Journal:  Am J Pathol       Date:  1992-02       Impact factor: 4.307

9.  Alveolar inflammation and arachidonate metabolism in monocrotaline-induced pulmonary hypertension.

Authors:  K R Stenmark; M L Morganroth; L K Remigio; N F Voelkel; R C Murphy; P M Henson; M M Mathias; J T Reeves
Journal:  Am J Physiol       Date:  1985-06

10.  Stimulation of transcription factors NF kappa B and AP1 in endothelial cells subjected to shear stress.

Authors:  Q Lan; K O Mercurius; P F Davies
Journal:  Biochem Biophys Res Commun       Date:  1994-06-15       Impact factor: 3.575

View more
  47 in total

Review 1.  Targeting soluble guanylate cyclase for the treatment of pulmonary hypertension.

Authors:  George F Lasker; Jason H Maley; Edward A Pankey; Philip J Kadowitz
Journal:  Expert Rev Respir Med       Date:  2011-04       Impact factor: 3.772

2.  Improved pulmonary vascular reactivity and decreased hypertrophic remodeling during nonhypercapnic acidosis in experimental pulmonary hypertension.

Authors:  Helen Christou; Ossama M Reslan; Virak Mam; Alain F Tanbe; Sally H Vitali; Marlin Touma; Elena Arons; S Alex Mitsialis; Stella Kourembanas; Raouf A Khalil
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-01-27       Impact factor: 5.464

Review 3.  Reversible or irreversible remodeling in pulmonary arterial hypertension.

Authors:  Seiichiro Sakao; Koichiro Tatsumi; Norbert F Voelkel
Journal:  Am J Respir Cell Mol Biol       Date:  2009-12-11       Impact factor: 6.914

4.  The cancer paradigm of severe pulmonary arterial hypertension.

Authors:  Pradeep R Rai; Carlyne D Cool; Judy A C King; Troy Stevens; Nana Burns; Robert A Winn; Michael Kasper; Norbert F Voelkel
Journal:  Am J Respir Crit Care Med       Date:  2008-06-12       Impact factor: 21.405

5.  ACE2 activation confers endothelial protection and attenuates neointimal lesions in prevention of severe pulmonary arterial hypertension in rats.

Authors:  Gang Li; Yinglong Liu; Yaobin Zhu; Aijun Liu; Yulin Xu; Xiaofeng Li; Zhiqiang Li; Junwu Su; Lizhong Sun
Journal:  Lung       Date:  2013-05-08       Impact factor: 2.584

6.  Reversal of experimental pulmonary hypertension by PDGF inhibition.

Authors:  Ralph Theo Schermuly; Eva Dony; Hossein Ardeschir Ghofrani; Soni Pullamsetti; Rajkumar Savai; Markus Roth; Akylbek Sydykov; Ying Ju Lai; Norbert Weissmann; Werner Seeger; Friedrich Grimminger
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

7.  Enhanced caveolin-1 expression in smooth muscle cells: Possible prelude to neointima formation.

Authors:  Jing Huang; John H Wolk; Michael H Gewitz; James E Loyd; James West; Eric D Austin; Rajamma Mathew
Journal:  World J Cardiol       Date:  2015-10-26

8.  Interleukin-6 overexpression induces pulmonary hypertension.

Authors:  M Kathryn Steiner; Olga L Syrkina; Narasaish Kolliputi; Eugene J Mark; Charles A Hales; Aaron B Waxman
Journal:  Circ Res       Date:  2008-12-12       Impact factor: 17.367

9.  Characterization of a murine model of monocrotaline pyrrole-induced acute lung injury.

Authors:  Rio Dumitrascu; Silke Koebrich; Eva Dony; Norbert Weissmann; Rajkumar Savai; Soni S Pullamsetti; Hossein A Ghofrani; Arun Samidurai; Horst Traupe; Werner Seeger; Friedrich Grimminger; Ralph T Schermuly
Journal:  BMC Pulm Med       Date:  2008-12-17       Impact factor: 3.317

10.  Simvastatin restores down-regulated GATA-6 expression in pulmonary hypertensive rats.

Authors:  Bin Liu; Xiao-qin Wang; Li Yu; Tong-fu Zhou; Xian-min Wang; Han-min Liu
Journal:  Exp Lung Res       Date:  2009-06       Impact factor: 2.459

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.